ALUVI Fundamental Analysis - UV GERMI SA

Fundamental Rating

ALUVI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 114 industry peers in the Machinery industry. ALUVI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALUVI has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALUVI had positive earnings in the past year.
ALUVI had positive earnings in 4 of the past 5 years.
In the past 5 years ALUVI always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of ALUVI (5.27%) is better than 66.67% of its industry peers.
ALUVI's Return On Equity of 5.80% is in line compared to the rest of the industry. ALUVI outperforms 42.98% of its industry peers.
With a Return On Invested Capital value of 3.15%, ALUVI is not doing good in the industry: 71.93% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	5.27%
ROE	5.8%
ROIC	3.15%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 7.75%, ALUVI is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
ALUVI's Profit Margin has improved in the last couple of years.
The Operating Margin of ALUVI (5.61%) is comparable to the rest of the industry.
The Gross Margin of ALUVI (51.20%) is better than 66.67% of its industry peers.
ALUVI's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	5.61%
PM (TTM)	7.75%
GM	51.2%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y40.03%

GM growth 3Y3.79%

GM growth 5Y5.14%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALUVI has about the same amout of shares outstanding than it did 1 year ago.
ALUVI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALUVI has been reduced compared to a year ago.

2.2 Solvency

ALUVI has an Altman-Z score of 6.25. This indicates that ALUVI is financially healthy and has little risk of bankruptcy at the moment.
ALUVI's Altman-Z score of 6.25 is amongst the best of the industry. ALUVI outperforms 94.74% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that ALUVI is not too dependend on debt financing.
ALUVI's Debt to Equity ratio of 0.00 is amongst the best of the industry. ALUVI outperforms 96.49% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	6.25

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 7.88 indicates that ALUVI has no problem at all paying its short term obligations.
ALUVI has a better Current ratio (7.88) than 98.25% of its industry peers.
A Quick Ratio of 5.51 indicates that ALUVI has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.51, ALUVI belongs to the best of the industry, outperforming 98.25% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	7.88
Quick Ratio	5.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALUVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.00%, which is quite impressive.
The Earnings Per Share has been growing by 42.53% on average over the past years. This is a very strong growth
Looking at the last year, ALUVI shows a decrease in Revenue. The Revenue has decreased by -9.66% in the last year.
The Revenue has been growing slightly by 6.64% on average over the past years.

EPS 1Y (TTM)200%

EPS 3YN/A

EPS 5Y42.53%

EPS Q2Q%-26.67%

Revenue 1Y (TTM)-9.66%

Revenue growth 3Y10.44%

Revenue growth 5Y6.64%

Sales Q2Q%-22.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.44 indicates a correct valuation of ALUVI.
Compared to the rest of the industry, the Price/Earnings ratio of ALUVI indicates a somewhat cheap valuation: ALUVI is cheaper than 75.44% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.33, ALUVI is valued a bit cheaper.

		Industry Rank	Sector Rank
PE	16.44
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)0.39

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALUVI!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

UV GERMI SA

EPA:ALUVI (1/14/2026, 7:00:00 PM)

2.96

+0.07 (+2.42%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)10-16 2025-10-16

Earnings (Next)N/A N/A

Inst Owners3.77%

Inst Owner ChangeN/A

Ins Owners26.64%

Ins Owner ChangeN/A

Market Cap9.56M

Revenue(TTM)7.48M

Net Income(TTM)580.00K

Analysts84.44

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	16.44
Fwd PE	N/A
P/S	1.28
P/FCF	N/A
P/OCF	N/A
P/B	0.98
P/tB	1.12
EV/EBITDA	N/A

EPS(TTM)0.18

EY6.08%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS2.32

BVpS3.02

TBVpS2.64

PEG (NY)N/A

PEG (5Y)0.39

Graham Number3.49

Profitability

		Industry Rank	Sector Rank
ROA	5.27%
ROE	5.8%
ROCE	4.29%
ROIC	3.15%
ROICexc	3.15%
ROICexgc	3.6%
OM	5.61%
PM (TTM)	7.75%
GM	51.2%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y40.03%

GM growth 3Y3.79%

GM growth 5Y5.14%

F-ScoreN/A

Asset Turnover0.68

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	7.88
Quick Ratio	5.51
Altman-Z	6.25

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)200%

EPS 3YN/A

EPS 5Y42.53%

EPS Q2Q%-26.67%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-9.66%

Revenue growth 3Y10.44%

Revenue growth 5Y6.64%

Sales Q2Q%-22.1%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y75%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

UV GERMI SA / ALUVI.PA FAQ

What is the fundamental rating for ALUVI stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALUVI.PA.

Can you provide the valuation status for UV GERMI SA?

ChartMill assigns a valuation rating of 1 / 10 to UV GERMI SA (ALUVI.PA). This can be considered as Overvalued.

What is the profitability of ALUVI stock?

UV GERMI SA (ALUVI.PA) has a profitability rating of 4 / 10.

What are the PE and PB ratios of UV GERMI SA (ALUVI.PA) stock?

The Price/Earnings (PE) ratio for UV GERMI SA (ALUVI.PA) is 16.44 and the Price/Book (PB) ratio is 0.98.

UV GERMI SA (ALUVI.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

UV GERMI SA / ALUVI.PA FAQ

What is the fundamental rating for ALUVI stock?

Can you provide the valuation status for UV GERMI SA?

What is the profitability of ALUVI stock?

What are the PE and PB ratios of UV GERMI SA (ALUVI.PA) stock?